针对瘤反应的T辅助细胞在针对质瘤的疫苗接种的背景下

Binghao Zhao1, Michael Kilian1, Theresa Bunse1

  • 1CCU Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neuroscience, Heidelberg University, Mannheim, Germany; German Cancer Consortium (DKTK), DKFZ, core center, Heidelberg, Germany.

Cancer cell
|October 20, 2023
PubMed
概括

帮助性T细胞 (THCs) 是抗癌免疫的关键,推动了新的质瘤疫苗的开发. 本综述探讨了THC机制及其在有效的癌症免疫治疗中的作用.